The ROP16(III)-dependent early immune response determines the subacute CNS immune response and type III Toxoplasma gondii survival

por Tuladhar, Shraddha, Kochanowsky, Joshua A., Bhaskara, Apoorva, Ghotmi, Yarah, Chandrasekaran, Sambamurthy, Koshy, Anita A.
Publicado 2019

Therapeutic Monoclonal Antibodies Targeting Immune Checkpoints for the Treatment of Solid Tumors

por Gravbrot, Nicholas, Gilbert-Gard, Kacy, Mehta, Paras, Ghotmi, Yarah, Banerjee, Madhulika, Mazis, Christopher, Sundararajan, Srinath
Publicado 2019